-
Posted by
Two Blokes May 22, 2025 -
Filed in
Stock
-
8 views
BOULDER, Colo., May 22, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will present at the following investor conferences: TD Cowen's 6th Annual Oncology Innovation Summit: Insights from ASCO & EHA Format: Fireside ChatDate: Tuesday, May 27, 2025 Time: 1:00 p.m.
